Mirtazapina Alter (Mirtazapine)

Mirtazapine, the active ingredient in Mirtazapina Alter, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for systemic use. It is prescribed for the treatment of major depressive disorder in adult patients, helping to alleviate depressive symptoms and improve mood.

GNH USA supplies Mirtazapina Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing through global healthcare providers and distribution networks.

Mirtazapine is indicated for depressive disorders and works by modulating noradrenergic and serotonergic neurotransmission, offering therapeutic benefit in several clinical presentations of depression. - Major depressive disorder (single episode): reduces depressive symptoms and improves mood in adult patients. - Major depressive disorder (recurrent): helps maintain remission and prevent relapse. - Depressive symptoms associated with anxiety: alleviates low mood and anxiety components in patients with comorbid conditions.

Mirtazapine may cause a range of adverse reactions, varying from mild to serious. Common Side Effects: - Sedation: drowsiness or feeling unusually sleepy. - Increased appetite: often leading to weight gain. - Dry mouth: reduced salivation causing discomfort. Serious or Rare Side Effects: - Agranulocytosis: severe reduction in white blood cells. - Seizures: rare occurrence of convulsive episodes. - Severe hypersensitivity: rash, swelling, or anaphylaxis.

When prescribing mirtazapine, clinicians should observe several precautionary measures to ensure safe use. - Monitor weight: patients often experience increased appetite and weight gain. - Assess sedation: advise caution when operating machinery or driving. - Screen for suicidal ideation: especially at therapy initiation or dose changes. - Use with hepatic impairment: dose adjustment may be required in liver disease. - Avoid abrupt discontinuation: taper under medical supervision to reduce withdrawal symptoms. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Mirtazapine can interact with other medicines, altering its efficacy or safety profile. Major Interactions (Avoid): - MAO inhibitors: concurrent use may cause hypertensive crisis or serotonin syndrome. - Other serotonergic agents: increased risk of serotonin syndrome when combined with SSRIs, SNRIs, or tramadol. - CNS depressants: additive sedation when taken with benzodiazepines or alcohol. Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors: may raise mirtazapine plasma levels, requiring dose adjustment. - Anticoagulants (e.g., warfarin): monitor INR as mirtazapine can affect clotting parameters.